Elsevier

Injury

Volume 31, Issue 9, November 2000, Pages 693-695
Injury

Are hip protectors cost effective?

https://doi.org/10.1016/S0020-1383(00)00078-4Get rights and content

Abstract

The purpose of this study is to assess the cost effectiveness of hip protectors in preventing proximal femoral or ‘hip’ fractures in the elderly. The incidence of ‘hip’ fractures within the different age groups and the number of patients admitted from institutional care was determined from a prospective audit of all ‘hip’ fractures over a four year period at our hospital. Compliance and estimation of the effectiveness of hip protectors was taken from data from the five randomised trials of hip protectors. The cost of using hip protectors was obtained from the manufacturers. There was long term compliance in 36% of population. There was a reduction of ‘hip’ fractures from 6.5 to 2.3%. The cost of using hip protectors was £113/person/year. For those aged over 80 years and for institutional care patients the wearing of hip protectors appears to be cost effective.

Introduction

Proximal femoral or ‘Hip’ fractures account for over 60,000 annual admissions into orthopaedic wards in England alone and is associated with a significant mortality and morbidity. The injury generally occurs in frail elderly patients as a consequence of a simple fall onto the hip [1]. Hip protectors (Fig. 1) have been devised to absorb the energy of the fall [2]. The purpose of this study is to determine the cost of using hip protectors in terms of the cost/fracture prevented.

Section snippets

Patients and methods

The cost of using hip protectors was obtained from the manufacturer [3]. Estimations for the number of hip protectors used by each person over a year were obtained by correspondence with authors of previous reports on hip protectors [2], [4], [5]. Compliance and estimation of the effectiveness of hip protectors was taken from data within the five randomised trials of hip protectors [4], [5], [6], [7], [8]. These randomised trials were identified by the Cochrane Collaboration Musculoskeletal

Results

The cost of providing hip protectors based on the provision of three pairs/year for all those who complied with wearing the protectors was £113/year. The five randomised trials gave information on the numbers who continued to wear the hip protectors. Summation of results for 694 participants from these studies indicated that overall long-term compliance with wearing the hip protectors occurred in 251 out of 694 trial participants (36%). Therefore, we estimate that it will cost about

Discussion

The average cost of treating a ‘hip’ fracture has been reported to be £7200 (adjusted to 1998 prices) [10]. The results of this study, therefore, indicate that for those aged over 84 years the wearing of hip protectors appears to be cost effective. Financial consequences and calculations take no account of the mortality and morbidity associated with a ‘hip’ fracture that would be avoided. It seems reasonable to conclude from these figures that hip protectors should be routinely provided to all

References (10)

There are more references available in the full text version of this article.

Cited by (27)

  • Systematic review of unintentional injury prevention economic evaluations 2010–2019 and comparison to 1998–2009

    2020, Accident Analysis and Prevention
    Citation Excerpt :

    The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Albert et al. (2016), Beard et al. (2006), Boswell et al. (2001), Brandt et al. (2002), Cafiso and D’agostino (2016), Camden et al. (2018), Carande-Kulis et al. (2015), Carter et al. (2015), Chen (2005), Church et al. (2012), Church et al. (2015), Claros et al. (2017), Colon-Emeric et al. (2003), Cooper et al. (2012), Daniels et al. (2019), Day et al. (2004), De Pauw et al. (2018), Eastridge et al. (2006), Frick et al. (2010b), Gandjour and Weyler (2008), Ginnelly et al. (2005), Goldstein et al. (2008), Graham and Chang (2015), Griffin et al. (2016), Haddix et al. (2001), Haines et al. (2009), Han et al. (2007), Harper et al. (2016), Hektoen et al. (2009), Honkanen et al. (2006), 2005, Isaranuwatchai et al. (2017), Johansson et al. (2008), Keall et al. (2017), Kedikoglou et al. (2005), Khan et al. (2019), Kopjar and Wickizer (2000), Kumar and Parker (2000), Lahausse and Fildes (2009), Li and Harmer (2015), Lindqvist and Lindholm (2001), Meuleners et al. (2008), Meyer et al. (2005), Miller et al. (2004), 2006, Miller et al. (2007), Mills et al. (2018), Myers et al. (2018), 2009, Myers et al. (2004), Pana-Cryan and Myers (2000), Ran et al. (2018), Redelmeier and Weinstein (1999), Robertson et al. (2001a), b, Robertson et al. (2001c), Rodgers and Leland (2008), Salkeld et al. (2000), Segui-Gomez et al. (2002), Singh et al. (2004), Smith and Widiatmoko (1998), Spetz et al. (2007), Spicer et al. (2004), Steinbach et al. (2013), Stollenwerk et al. (2014), Taylor and Scuffham (2002), Thompson et al. (2002), Tompa et al. (2016), Verhagen et al. (2005), Viamonte et al. (2006), Woods et al. (2008) and Zacker and Shea (1998). Mallika Mahalingam: Conceptualization, Methodology, Writing - original draft.

  • Systematic review and quality assessment of economic evaluation studies of injury prevention

    2012, Accident Analysis and Prevention
    Citation Excerpt :

    There were also eight studies that did not include the costs of the intervention in the cost calculations (Table 5). Almost all studies (except (Kumar and Parker, 2000; Salkeld et al., 2000; Robertson et al., 2001a; Spetz et al., 2007)) delivered information about the data source of the unit costs used, of which fourteen studies also recorded the currency and price data. The sources of health care resources (or effectiveness estimates) used were stated in 18 studies (see Table 5).

  • Hip protector: life remains the same

    2019, Medicina Clinica Practica
View all citing articles on Scopus
View full text